Evidence map›Paper›PMID 32903038›Full record

ArticleExperimental biology and medicine (Maywood, N.J.)2020

Orally administered emu oil attenuates disease in a mouse model of Crohn's-like colitis.

Chloe J Mitchell, Gordon S Howarth, Lauren C Chartier, Debbie Trinder, Ian C Lawrance, Li San Huang, Suzanne Mashtoub

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Experimental biology and medicine (Maywood, N.J.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Emu Oil and zinc monoglycerolate independently reduce disease severity in a rat model of ulcerative colitis.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2023
    Article
  2. Review
  3. Comparison of the healing effects of mesazaline andAnnals of surgical treatment and research · 2022
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Chloe J MitchellGastroenterology Department, Women's and Children's Hospital, North Adelaide, South Australia 5006, Australia.
Gordon S HowarthGastroenterology Department, Women's and Children's Hospital, North Adelaide, South Australia 5006, Australia.
Lauren C ChartierGastroenterology Department, Women's and Children's Hospital, North Adelaide, South Australia 5006, Australia.ORCID 0000-0001-7068-627X
Debbie TrinderSchool of Medicine, University of Western Australia, Murdoch, Western Australia 6150, Australia.
Ian C LawranceSchool of Medicine, University of Western Australia, Murdoch, Western Australia 6150, Australia.
Li San HuangSchool of Animal and Veterinary Sciences, University of Adelaide, Roseworthy, South Australia 5371, Australia.
Suzanne MashtoubGastroenterology Department, Women's and Children's Hospital, North Adelaide, South Australia 5006, Australia.
Women's and Children's Hospital · AUSt John of God Subiaco Hospital · AUThe University of Adelaide · AUThe University of Western Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Crohn's disease is a severe, incurable inflammatory bowel disease. Orally administered emu oil has demonstrated anti-inflammatory properties in previous models of gastrointestinal disease. We aimed to determine whether orally administered emu oil could attenuate disease in a mouse model of Crohn's-like colitis. Female ARC(s) mice (CD-1 equivalent,

Indexed as

Administration, OralAnimalsBody WeightColitisColonColonoscopyCrohn DiseaseDisease Models, AnimalFemaleIntestinal MucosaMiceOilsOrgan SizePermeabilityPeroxidaseemu OilOilsPeroxidaseCrohn’s diseaseEmu oilgastroenterologyinflammatory bowel diseasemouse modelnutraceutical

Identifiers

PMID32903038
PMCPMC7802385
OpenAlexW3084313144

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.